Creegan & Nassoura Financial Group’s Thermo Fisher Scientific TMO Stock Holding History

Creegan & Nassoura Financial Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$444K	Hold	767	–	–	0.29%	66
2025 Q3	$372K	Hold	767	–	–	0.24%	65
2025 Q2	$311K	Hold	767	–	–	0.2%	69
2025 Q1	$382K	Hold	767	–	–	0.25%	68
2024 Q4	$399K	Hold	767	–	–	0.27%	67
2024 Q3	$474K	Hold	767	–	–	0.3%	66
2024 Q2	$424K	Hold	767	–	–	0.29%	65
2024 Q1	$446K	Hold	767	–	–	0.3%	65
2023 Q4	$407K	Hold	767	–	–	0.3%	68
2023 Q3	$388K	Hold	767	–	–	0.3%	67
2023 Q2	$400K	Hold	767	–	–	0.3%	66
2023 Q1	$442K	Hold	767	–	–	0.34%	67
2022 Q4	$422K	Hold	767	–	–	0.33%	66
2022 Q3	$389K	Hold	767	–	–	0.34%	70
2022 Q2	$417K	Hold	767	–	–	0.35%	64
2022 Q1	$453K	Hold	767	–	–	0.34%	66
2021 Q4	$512K	Hold	767	–	–	0.39%	66
2021 Q3	$438K	Sell	767 -150	-16%	-$82.3K	0.37%	65
2021 Q2	$463K	Hold	917	–	–	0.4%	62
2021 Q1	$419K	Hold	917	–	–	0.37%	61
2020 Q4	$427K	Hold	917	–	–	0.41%	58
2020 Q3	$405K	Hold	917	–	–	0.44%	57
2020 Q2	$332K	Hold	917	–	–	0.37%	61
2020 Q1	$260K	Hold	917	–	–	0.34%	62
2019 Q4	$298K	Buy	+917	New	+$278K	0.3%	68

Other funds holding TMO

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Creegan & Nassoura Financial Group's TMO Position: Q4 2025 in Review

Creegan & Nassoura Financial Group held its Thermo Fisher Scientific (TMO) position steady in Q4 2025 at 767 shares worth $444K. The position accounts for 0.29% of the portfolio, ranked #66.

Creegan & Nassoura Financial Group first reported a position in TMO in Q4 2019 and has held it in 25 quarters since. The position peaked at $512K in Q4 2021. 2,700 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

Creegan & Nassoura Financial Group held 767 shares of Thermo Fisher Scientific worth $444K as of Q4 2025.
Creegan & Nassoura Financial Group left its Thermo Fisher Scientific share count unchanged in Q4 2025.
Thermo Fisher Scientific made up 0.29% of Creegan & Nassoura Financial Group's portfolio in Q4 2025, its #66 holding.
Creegan & Nassoura Financial Group first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 25 quarters since.
Creegan & Nassoura Financial Group's Thermo Fisher Scientific position peaked at $512K in Q4 2021.
2,700 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Creegan & Nassoura Financial Group's 13F filing for Q4 2025, filed 17 Feb 2026.